These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 32155747)
1. Carotid Atherosclerosis Progression in Postmenopausal Women Receiving a Mixed Phytoestrogen Regimen: Plausible Parallels with Kronos Early Estrogen Replacement Study. Kirichenko TV; Myasoedova VA; Ravani AL; Sobenin IA; Orekhova VA; Romanenko EB; Poggio P; Wu WK; Orekhov AN Biology (Basel); 2020 Mar; 9(3):. PubMed ID: 32155747 [TBL] [Abstract][Full Text] [Related]
2. Anti-Atherosclerotic Effects of a Phytoestrogen-Rich Herbal Preparation in Postmenopausal Women. Myasoedova VA; Kirichenko TV; Melnichenko AA; Orekhova VA; Ravani A; Poggio P; Sobenin IA; Bobryshev YV; Orekhov AN Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529226 [TBL] [Abstract][Full Text] [Related]
3. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol. Hodis HN; Mack WJ; Henderson VW; Shoupe D; Budoff MJ; Hwang-Levine J; Li Y; Feng M; Dustin L; Kono N; Stanczyk FZ; Selzer RH; Azen SP; N Engl J Med; 2016 Mar; 374(13):1221-31. PubMed ID: 27028912 [TBL] [Abstract][Full Text] [Related]
4. Effects of phytoestrogen supplementation on intermediate cardiovascular disease risk factors among postmenopausal women: a meta-analysis of randomized controlled trials. Wolters M; Dejanovic GM; Asllanaj E; Günther K; Pohlabeln H; Bramer WM; Ahrens J; Nagrani R; Pigeot I; Franco OH; Ahrens W; Muka T; Glisic M Menopause; 2020 Sep; 27(9):1081-1092. PubMed ID: 32852463 [TBL] [Abstract][Full Text] [Related]
5. Differential Effect of Plasma Estradiol on Subclinical Atherosclerosis Progression in Early vs Late Postmenopause. Sriprasert I; Hodis HN; Karim R; Stanczyk FZ; Shoupe D; Henderson VW; Mack WJ J Clin Endocrinol Metab; 2019 Feb; 104(2):293-300. PubMed ID: 30272234 [TBL] [Abstract][Full Text] [Related]
6. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. Crouse JR; Raichlen JS; Riley WA; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Bots ML; JAMA; 2007 Mar; 297(12):1344-53. PubMed ID: 17384434 [TBL] [Abstract][Full Text] [Related]
7. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Hodis HN; Mack WJ; Lobo RA; Shoupe D; Sevanian A; Mahrer PR; Selzer RH; Liu Cr CR; Liu Ch CH; Azen SP; Ann Intern Med; 2001 Dec; 135(11):939-53. PubMed ID: 11730394 [TBL] [Abstract][Full Text] [Related]
8. Effect of menopausal hormone therapy on arterial wall echomorphology: Results from the Early versus Late Intervention Trial with Estradiol (ELITE). Karim R; Xu W; Kono N; Sriprasert I; Li Y; Yan M; Stanczyk FZ; Shoupe D; Mack WJ; Hodis HN Maturitas; 2022 Aug; 162():15-22. PubMed ID: 35474254 [TBL] [Abstract][Full Text] [Related]
9. Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study. Bots ML; Palmer MK; Dogan S; Plantinga Y; Raichlen JS; Evans GW; O'Leary DH; Grobbee DE; Crouse JR; J Intern Med; 2009 Jun; 265(6):698-707. PubMed ID: 19298496 [TBL] [Abstract][Full Text] [Related]
10. Difference in carotid intima-media thickness between pre and postmenopausal women. Ieamtairat P; Soontrapa S; Kaewrudee S; Promsorn J; Takong W; Somboonporn W Menopause; 2019 Jan; 26(1):39-44. PubMed ID: 29975281 [TBL] [Abstract][Full Text] [Related]
11. The association of hysterectomy with or without ovarian conservation with subclinical atherosclerosis progression in healthy postmenopausal women. Chen IJ; Shoupe D; Karim R; Stanczyk FZ; Kono N; Sriprasert I; Hodis HN; Mack WJ Menopause; 2023 Jul; 30(7):692-702. PubMed ID: 37192828 [TBL] [Abstract][Full Text] [Related]
12. Carotid intima-media thickness and calcification in relation to bone mineral density in postmenopausal women-the OSTPRE-BBA study. Värri M; Tuomainen TP; Honkanen R; Rikkonen T; Niskanen L; Kröger H; Tuppurainen MT Maturitas; 2014 Aug; 78(4):304-9. PubMed ID: 24954699 [TBL] [Abstract][Full Text] [Related]
13. Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: results from the estrogen in the prevention of atherosclerosis trial. Mack WJ; Hameed AB; Xiang M; Roy S; Slater CC; Stanczyk FZ; Lobo RA; Liu CR; Liu CH; Hodis HN Atherosclerosis; 2003 May; 168(1):91-8. PubMed ID: 12732391 [TBL] [Abstract][Full Text] [Related]
14. A randomized placebo controlled trial of an innovative herbal formula in the prevention of atherosclerosis in postmenopausal women with borderline hypercholesterolemia. Kwok T; Leung PC; Lam C; Ho S; Wong CK; Cheng KF; Chook P Complement Ther Med; 2014 Jun; 22(3):473-80. PubMed ID: 24906587 [TBL] [Abstract][Full Text] [Related]
15. Changes in carotid artery intima-media thickness 3 years after cessation of menopausal hormone therapy: follow-up from the Kronos Early Estrogen Prevention Study. Miller VM; Hodis HN; Lahr BD; Bailey KR; Jayachandran M Menopause; 2019 Jan; 26(1):24-31. PubMed ID: 30020254 [TBL] [Abstract][Full Text] [Related]
16. Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis. Hodis HN; Mack WJ; Shoupe D; Azen SP; Stanczyk FZ; Hwang-Levine J; Budoff MJ; Henderson VW Menopause; 2015 Apr; 22(4):391-401. PubMed ID: 25380275 [TBL] [Abstract][Full Text] [Related]
17. Carotid artery intima-media thickness after raloxifene treatment. Mack WJ; Dhungana B; Dowsett SA; Keech CA; Feng M; Li Y; Hodis HN J Womens Health (Larchmt); 2007 Apr; 16(3):370-8. PubMed ID: 17439382 [TBL] [Abstract][Full Text] [Related]
18. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial. Zhang G; Qin L; Shi Y J Bone Miner Res; 2007 Jul; 22(7):1072-9. PubMed ID: 17419678 [TBL] [Abstract][Full Text] [Related]